Globally launched clinical trials like the European study DISCOVERY showed that antiviral drugs (remdesivir, lopinavir and ritonavir in combination, ritonavir given with or without interferon beta and hydroxychloroquine) are unable to efficiently attack COVID-19 progression (Ader et al., 2022)
Results showed that CagriSema: Reduced body weight significantly more than with either monotherapy: CagriSema: 15.6%, Semaglutide: 5.1%, and Cagrilintide: 8.1%
To date, the results have been highly satisfactory, and I intend to continue this practice
On the other hand, some antibiotics like rifampin speed up tacrolimus metabolism, lowering its concentration and potentially leading to transplant rejection
KannanRZhangNSreekumarPGSpeeCKRodriguezABarronEet alStimulation of apical and basolateral VEGF-A and VEGF-C secretion by oxidative stress in polarized retinal pigment epithelial cells